Proof-of-concept evaluation of multi-parametric MRI (LiverMultiScan) for non-invasive assessment of portal hypertension. Spleen cT1 emerged as a promising marker of portal pressure, outperforming established non-invasive scores and indicating potential for safer, more accurate monitoring.